Gymnemic Acids

Gymnemic Acids at a Glance

Gymnemic acids are not a single molecule but a complex of closely related oleanane-type triterpenoid saponins — gymnemic acids I–VII and beyond, alongside the related gymnemosides and gymnemasaponins — that are the principal active markers of Gymnema sylvestre leaf ^{1,12Reference 1Tiwari P et al. · 2014Phytochemical and pharmacological properties of Gymnema sylvestre: an important medicinal plantView study →Reference 12Yoshikawa M et al. · 1997Medicinal foodstuffsView study →}. In India the plant is called gurmar, “the sugar destroyer,” and the name captures the compound-defining trick: chew the leaf and, for the next half hour or so, sugar tastes of almost nothing.

Two activities carry it. First, the antisweet effect — gymnemic acids reversibly bind the human sweet-taste receptor so that sweet foods lose their sweetness ^{3Reference 3Sanematsu K et al. · 2014Molecular mechanisms for sweet-suppressing effect of gymnemic acidsView study →}. Second, an antidiabetic / glucose-absorption effect — they slow the uptake of glucose (and fat) at the intestinal wall, and Gymnema leaf extract has genuine human glycaemic data behind it ^{4,6,8Reference 4Baskaran K et al. · 1990Antidiabetic effect of a leaf extract from Gymnema sylvestre in non-insulin-dependent diabetes mellitus patientsView study →Reference 6Devangan S et al. · 2021Meta-analysisThe effect of Gymnema sylvestre supplementation on glycemic control in type 2 diabetes patients: a systematic review and meta-analysisView study →Reference 8Gaytán Martínez LA et al. · 2021Clinical trialEffect of Gymnema sylvestre administration on glycemic control, insulin secretion, and insulin sensitivity in patients with impaired glucose toleranceView study →}.

The honest framing matters throughout. Both signature effects are local — one on the tongue, one in the gut lumen — so the class-typical poor oral bioavailability of a big saponin does not undercut them the way it undercuts systemic saponin claims. But the human clinical evidence almost always uses the whole standardised leaf extract (GS4, or 25%/75% gymnemic-acid extracts), not the isolated acids, and the celebrated “beta-cell regeneration” reading of those trials is the part that would require systemic action and remains the least secure ^{4,5Reference 4Baskaran K et al. · 1990Antidiabetic effect of a leaf extract from Gymnema sylvestre in non-insulin-dependent diabetes mellitus patientsView study →Reference 5Shanmugasundaram ER et al. · 1990Use of Gymnema sylvestre leaf extract in the control of blood glucose in insulin-dependent diabetes mellitusView study →}.

The Antisweet Effect (“Gurmar, the Sugar Destroyer”)

The sweet-suppressing action is what makes this compound famous, and it is the clearest window onto how it works. Place gymnemic acid on the tongue and, within seconds, the sweetness of sugar, high-intensity sweeteners and sweet fruit collapses to a flat, watery taste — while sour, salty, bitter and umami are left essentially intact ^{3,16Reference 3Sanematsu K et al. · 2014Molecular mechanisms for sweet-suppressing effect of gymnemic acidsView study →Reference 16Pickrahn S et al. · 2021Sensory-guided multidimensional exploration of antisweet principles from Gymnema sylvestre (Retz) SchultView study →}. The effect is reversible, fades over roughly 15–60 minutes, and — tellingly — is abolished immediately by rinsing the mouth with γ-cyclodextrin, which sequesters the gymnemic acid away from the receptor ^{3Reference 3Sanematsu K et al. · 2014Molecular mechanisms for sweet-suppressing effect of gymnemic acidsView study →}.

The molecular basis was pinned down using cells engineered to display the human sweet receptor. Gymnemic acids inhibit the calcium response of the human T1R2 + T1R3 sweet receptor but do not inhibit the mouse version — a striking species specificity ^{3Reference 3Sanematsu K et al. · 2014Molecular mechanisms for sweet-suppressing effect of gymnemic acidsView study →}. Chimera and mutagenesis work localised the action to the transmembrane domain of the human T1R3 subunit, at the same site that binds the synthetic sweet-blocker lactisole; the shared glucuronic-acid moiety of the gymnemic acids is enough to reduce sweet sensitivity on its own, and the molecule is predicted to dock into a pocket within that transmembrane domain ^{3Reference 3Sanematsu K et al. · 2014Molecular mechanisms for sweet-suppressing effect of gymnemic acidsView study →}. This is why Gymnema is such a useful research tool for sweet-taste biology, and why rodent taste experiments do not translate to it.

The behavioural consequence has been tested in people. In placebo-controlled experiments a gymnemic-acid lozenge acutely cut short-term consumption of high-sugar food and reduced its pleasantness ^{14Reference 14Stice E et al. · 2017RCTGymnemic acids lozenge reduces short-term consumption of high-sugar food: a placebo controlled experimentView study →}, and consuming Gymnema reduced the desire for high-sugar sweet foods in a controlled human study ^{15Reference 15Turner S et al. · 2020Consuming Gymnema sylvestre reduces the desire for high-sugar sweet foodsView study →}. These are short, small studies of appetite/behaviour rather than weight-loss trials, but they are among the cleaner pieces of human isolate-adjacent evidence on the page.

What It's Used For

Beyond the antisweet trick, gymnemic acids sit behind Gymnema’s traditional antidiabetic reputation. The evidence separates sharply into two kinds: isolate/fraction studies of the glucose- and fat-absorption mechanism (mostly in vitro and in rodents), and whole-extract human trials of glycaemic control that cannot be attributed to the gymnemic acids alone.

Evidence by IndicationStrength of support · Beta

Support is an experimental score — weighted by study type (human > animal > in vitro) and volume. A beta, not a validated metric. The antisweet score reflects direct human sensory + mechanistic data on the isolate; the glycaemic score leans on whole-extract human trials, not the pure acids.

01Antisweet / Sweet-Taste SuppressionPromising58%Human T1R3 mechanism + placebo-controlled lozenge/appetite studies ^{3,14,15Reference 3Sanematsu K et al. · 2014Molecular mechanisms for sweet-suppressing effect of gymnemic acidsView study →Reference 14Stice E et al. · 2017RCTGymnemic acids lozenge reduces short-term consumption of high-sugar food: a placebo controlled experimentView study →Reference 15Turner S et al. · 2020Consuming Gymnema sylvestre reduces the desire for high-sugar sweet foodsView study →}

02Glycaemic Control / AntidiabeticPromising48%Whole-extract (GS4) human meta-analyses + isolate glucose-absorption mechanism ^{4,6,8,9Reference 4Baskaran K et al. · 1990Antidiabetic effect of a leaf extract from Gymnema sylvestre in non-insulin-dependent diabetes mellitus patientsView study →Reference 6Devangan S et al. · 2021Meta-analysisThe effect of Gymnema sylvestre supplementation on glycemic control in type 2 diabetes patients: a systematic review and meta-analysisView study →Reference 8Gaytán Martínez LA et al. · 2021Clinical trialEffect of Gymnema sylvestre administration on glycemic control, insulin secretion, and insulin sensitivity in patients with impaired glucose toleranceView study →Reference 9Shimizu K et al. · 1997Suppression of glucose absorption by some fractions extracted from Gymnema sylvestre leavesView study →}

03Anti-Obesity / Lipid LoweringShaky30%Meta-analysed lipid drops (whole extract) + fat-absorption inhibition in rats ^{2,7,10Reference 2Pothuraju R et al. · 2014Systematic reviewA systematic review of Gymnema sylvestre in obesity and diabetes managementView study →Reference 7Zamani M et al. · 2023Meta-analysisThe effects of Gymnema sylvestre supplementation on lipid profile, glycemic control, blood pressure, and anthropometric indices in adults: a systematic review and meta-analysisView study →Reference 10Wang LF et al. · 1998AnimalInhibitory effect of gymnemic acid on intestinal absorption of oleic acid in ratsView study →}

Mechanisms

Pharmacokinetics

The most important pharmacokinetic point about gymnemic acids is that their two signature effects don’t depend on absorption at all. The antisweet action is a topical, lingual event — direct binding to sweet receptors on the tongue, reversed by rinsing — and the glucose/fat-absorption action happens in the gut lumen at the intestinal wall ^{3,9,10Reference 3Sanematsu K et al. · 2014Molecular mechanisms for sweet-suppressing effect of gymnemic acidsView study →Reference 9Shimizu K et al. · 1997Suppression of glucose absorption by some fractions extracted from Gymnema sylvestre leavesView study →Reference 10Wang LF et al. · 1998AnimalInhibitory effect of gymnemic acid on intestinal absorption of oleic acid in ratsView study →}. Neither requires the molecule to enter the bloodstream, which is fortunate: as large, glucuronidated oleanane triterpenoid saponins, gymnemic acids have the class-typical liabilities — poor passive membrane permeability and extensive gut/microbial hydrolysis toward their sapogenin (gymnemagenin) and deacylated products ^{1,12Reference 1Tiwari P et al. · 2014Phytochemical and pharmacological properties of Gymnema sylvestre: an important medicinal plantView study →Reference 12Yoshikawa M et al. · 1997Medicinal foodstuffsView study →}. There is no validated human pharmacokinetic study of the isolated acids, and any systemic claim (e.g. direct beta-cell effects) has to reckon with this low bioavailability.

Clinical Trials

There are no clinical trials of isolated gymnemic acids as a drug. The human evidence is either (a) short sensory/appetite experiments using gymnemic-acid lozenges ^{14,15Reference 14Stice E et al. · 2017RCTGymnemic acids lozenge reduces short-term consumption of high-sugar food: a placebo controlled experimentView study →Reference 15Turner S et al. · 2020Consuming Gymnema sylvestre reduces the desire for high-sugar sweet foodsView study →}, or (b) glycaemic/lipid trials of the whole standardised leaf extract (GS4 and 25%/75% extracts), now pooled in two systematic reviews/meta-analyses ^{6,7,8Reference 6Devangan S et al. · 2021Meta-analysisThe effect of Gymnema sylvestre supplementation on glycemic control in type 2 diabetes patients: a systematic review and meta-analysisView study →Reference 7Zamani M et al. · 2023Meta-analysisThe effects of Gymnema sylvestre supplementation on lipid profile, glycemic control, blood pressure, and anthropometric indices in adults: a systematic review and meta-analysisView study →Reference 8Gaytán Martínez LA et al. · 2021Clinical trialEffect of Gymnema sylvestre administration on glycemic control, insulin secretion, and insulin sensitivity in patients with impaired glucose toleranceView study →}. Attribution to the single compound is therefore not possible from the trial record.

Last checked: July 2026.

Whole Extract (GS4) vs. Isolated Gymnemic Acids

This is the load-bearing distinction for reading the evidence honestly. GS4 (and the 25%/75% gymnemic-acid extracts) is a water-soluble whole-leaf extract standardised to gymnemic-acid content — not the purified compound. The long-running human diabetes studies, the impaired-glucose-tolerance RCT and every meta-analysed glycaemic trial used this extract, at 400 mg/day or comparable ^{4,5,8Reference 4Baskaran K et al. · 1990Antidiabetic effect of a leaf extract from Gymnema sylvestre in non-insulin-dependent diabetes mellitus patientsView study →Reference 5Shanmugasundaram ER et al. · 1990Use of Gymnema sylvestre leaf extract in the control of blood glucose in insulin-dependent diabetes mellitusView study →Reference 8Gaytán Martínez LA et al. · 2021Clinical trialEffect of Gymnema sylvestre administration on glycemic control, insulin secretion, and insulin sensitivity in patients with impaired glucose toleranceView study →}. The isolated-compound evidence, by contrast, is the mechanism layer: sweet-receptor blockade in engineered human cells ^{3Reference 3Sanematsu K et al. · 2014Molecular mechanisms for sweet-suppressing effect of gymnemic acidsView study →}, glucose- and fat-absorption inhibition in ex-vivo gut and rats ^{9,10,11Reference 9Shimizu K et al. · 1997Suppression of glucose absorption by some fractions extracted from Gymnema sylvestre leavesView study →Reference 10Wang LF et al. · 1998AnimalInhibitory effect of gymnemic acid on intestinal absorption of oleic acid in ratsView study →Reference 11Shimizu K et al. · 2001Structure-activity relationships of triterpenoid derivatives extracted from Gymnema inodorum leaves on glucose absorptionView study →}, and structure–activity work on the gymnemosides ^{12Reference 12Yoshikawa M et al. · 1997Medicinal foodstuffsView study →}.

The two layers point the same way, which is reassuring, but they are not interchangeable. Standardisation is complicated further by botany: roughly 50 Gymnema species (and a variable leaf gymnemic-acid content of ~0.67–1.06%) are traded somewhat interchangeably, so “Gymnema extract” in one trial is not chemically identical to another ^{1Reference 1Tiwari P et al. · 2014Phytochemical and pharmacological properties of Gymnema sylvestre: an important medicinal plantView study →}. When the human evidence is said to be is “for the extract,” that caveat is doing real work — the gymnemic acids are the plausible active fraction, not a proven single-agent drug.

Its Role in the Plant

In Gymnema sylvestre the gymnemic acids are oleanane-type triterpenoid saponins, built on an oleanolic-acid–type triterpene backbone (compare the free triterpene oleanolic acid and the related ursolic acid) decorated with sugar and acyl groups, with gymnemagenin as the shared aglycone ^{1,12Reference 1Tiwari P et al. · 2014Phytochemical and pharmacological properties of Gymnema sylvestre: an important medicinal plantView study →Reference 12Yoshikawa M et al. · 1997Medicinal foodstuffsView study →}. In this they are close structural kin of the other oleanane triterpenoid saponins in the medicinal flora — Bupleurum’s saikosaponin A and Centella’s asiaticoside — sharing the pentacyclic backbone but differing in their sugar/acyl decoration and, crucially, in what that decoration lets them bind. Like other plant saponins they are best understood as chemical defence: their soap-like, membrane-disrupting amphipathy deters herbivores and microbes, and their intense interference with sweet perception may itself discourage feeding. They accumulate in the leaf, the traditionally used part, at levels that vary with species, provenance and harvest time ^{1Reference 1Tiwari P et al. · 2014Phytochemical and pharmacological properties of Gymnema sylvestre: an important medicinal plantView study →}.

Prevalence in Nature

Gymnemic acids are effectively a chemotaxonomic signature of Gymnema (family Apocynaceae, formerly Asclepiadaceae). The principal source is the leaf of Gymnema sylvestre, where the gymnemic-acid complex makes up only about 0.67–1.06% of the dried leaf and is accompanied by the gymnemosides, gymnemasaponins, the aglycone gymnemagenin, and a separate antisweet peptide, gurmarin (a 35-residue protein that blocks sweet taste in rodents but is weak in humans — mechanistically the mirror image of the gymnemic acids) ^{1,19Reference 1Tiwari P et al. · 2014Phytochemical and pharmacological properties of Gymnema sylvestre: an important medicinal plantView study →Reference 19Sigoillot M et al. · 2018The crystal structure of gurmarin, a sweet taste-suppressing protein: identification of the amino acid residues essential for inhibitionView study →}. Related antisweet triterpenoids occur in Gymnema inodorum and other Gymnema species, whose leaf saponins show the same glucose-absorption–inhibiting structure–activity pattern ^{11Reference 11Shimizu K et al. · 2001Structure-activity relationships of triterpenoid derivatives extracted from Gymnema inodorum leaves on glucose absorptionView study →}. Because raw-leaf content is low and variable, commercial material is concentrated to standardised 25% or 75% gymnemic-acid extracts ^{1Reference 1Tiwari P et al. · 2014Phytochemical and pharmacological properties of Gymnema sylvestre: an important medicinal plantView study →}.

Discovery & Synthesis

The antisweet property of Gymnema sylvestre leaf was recorded by Western observers in the late nineteenth century, and the taste-modifying principle was named for the plant’s Hindi epithet gurmar. The individual gymnemic acids (I–VII and beyond) and the gymnemosides were isolated and structurally elucidated largely across the 1980s and 1990s, notably in the “Medicinal Foodstuffs” series by Yoshikawa and colleagues, who defined the gymnemosides and linked their structures to glucose-absorption inhibition ^{12Reference 12Yoshikawa M et al. · 1997Medicinal foodstuffsView study →}. The molecular target of the antisweet effect — the transmembrane domain of the human T1R3 sweet-receptor subunit — was mapped much more recently, in 2014 ^{3Reference 3Sanematsu K et al. · 2014Molecular mechanisms for sweet-suppressing effect of gymnemic acidsView study →}.

There is no commercial total synthesis: gymnemic acids are large, multiply-glycosylated triterpene saponins, and manufacture is entirely by extraction and standardisation from Gymnema leaf. Because wild leaf content is low and variable, interest has turned to biotechnological production — cell/tissue culture and elicitation strategies to raise gymnemic-acid yield — which is reviewed as the realistic path to a consistent supply rather than chemical synthesis ^{17Reference 17Al-Khayri JM et al. · 2023Biotechnological approaches for the production of gymnemic acid from Gymnema sylvestre RView study →}.

Patents: not yet researched.

Toxicity & Safety

Gymnemic acids carry a low toxicity flag. Gymnema sylvestre leaf has a long record of traditional use and a reassuring safety profile in the human trials to date, where adverse effects were generally mild ^{1,6Reference 1Tiwari P et al. · 2014Phytochemical and pharmacological properties of Gymnema sylvestre: an important medicinal plantView study →Reference 6Devangan S et al. · 2021Meta-analysisThe effect of Gymnema sylvestre supplementation on glycemic control in type 2 diabetes patients: a systematic review and meta-analysisView study →}. The two real cautions are pharmacological consequences of what the compound does, not signs of intrinsic toxicity.

Safety at a Glance

✅ Low / no toxicity

• Long traditional use, generally well tolerated. Human glycaemic trials of standardised extract report mainly mild adverse effects ^{1,6Reference 1Tiwari P et al. · 2014Phytochemical and pharmacological properties of Gymnema sylvestre: an important medicinal plantView study →Reference 6Devangan S et al. · 2021Meta-analysisThe effect of Gymnema sylvestre supplementation on glycemic control in type 2 diabetes patients: a systematic review and meta-analysisView study →}.
• Additive hypoglycaemia risk. Because it lowers glucose, combining Gymnema with insulin or oral antidiabetic drugs can push blood sugar too low — the classic GS4 study deliberately reduced conventional drug doses ^{4,5Reference 4Baskaran K et al. · 1990Antidiabetic effect of a leaf extract from Gymnema sylvestre in non-insulin-dependent diabetes mellitus patientsView study →Reference 5Shanmugasundaram ER et al. · 1990Use of Gymnema sylvestre leaf extract in the control of blood glucose in insulin-dependent diabetes mellitusView study →}.
• The antisweet effect is itself a side effect. Sweetness (and the pleasure of sweet food) is blunted for up to an hour after oral exposure — usually the point, occasionally unwanted.
• Saponins are irritant/haemolytic at high concentration. A generic class property of triterpenoid saponins, relevant to concentrated material.

Full Safety & Interactions Detail

The headline interaction is additive glucose lowering: because gymnemic acids reduce glucose absorption and Gymnema extract lowers fasting glucose and HbA1c, co-use with insulin or oral hypoglycaemics can produce hypoglycaemia — indeed the long-term GS4 trials showed patients could decrease their conventional medication, and five of twenty-two discontinued it, which is exactly the setting where uncoordinated dosing could overshoot ^{4,5Reference 4Baskaran K et al. · 1990Antidiabetic effect of a leaf extract from Gymnema sylvestre in non-insulin-dependent diabetes mellitus patientsView study →Reference 5Shanmugasundaram ER et al. · 1990Use of Gymnema sylvestre leaf extract in the control of blood glucose in insulin-dependent diabetes mellitusView study →}.

Anyone on diabetes medication should treat Gymnema as pharmacologically active and monitor accordingly. Beyond this, the compound’s antisweet action is a predictable, reversible “effect” that some users find unpleasant. As triterpenoid saponins, gymnemic acids share the class’s mild irritant and haemolytic potential at high concentration, though this is not a feature of ordinary standardised-extract intake. Dedicated reproductive-toxicity data for the isolated acids are lacking; any pregnancy/lactation decision belongs to the Gymnema herb or product page, where intake is decided, not to this molecule page.

Dosage

There is no established dose for isolated gymnemic acids — they have never been used as a stand-alone drug. The figures in the literature belong to Gymnema preparations standardised to gymnemic-acid content:

Raw-leaf gymnemic-acid content is low and variable (~0.67–1.06%), so standardised extracts — not crude leaf — are what the human evidence rests on ^{1Reference 1Tiwari P et al. · 2014Phytochemical and pharmacological properties of Gymnema sylvestre: an important medicinal plantView study →}. These are doses studied in research and are not a personal recommendation.

References

1. Tiwari P, Mishra BN, Sangwan NS (2014). Phytochemical and pharmacological properties of Gymnema sylvestre: an important medicinal plant. BioMed Research International. https://pubmed.ncbi.nlm.nih.gov/24511547/
2. Pothuraju R, Sharma RK, Chagalamarri J, et al. (2014). A systematic review of Gymnema sylvestre in obesity and diabetes management. Journal of the Science of Food and Agriculture. https://pubmed.ncbi.nlm.nih.gov/24166097/
3. Sanematsu K, Kusakabe Y, Shigemura N, et al. (2014). Molecular mechanisms for sweet-suppressing effect of gymnemic acids. Journal of Biological Chemistry. https://pubmed.ncbi.nlm.nih.gov/25056955/
4. Baskaran K, Kizar Ahamath B, Radha Shanmugasundaram K, Shanmugasundaram ER (1990). Antidiabetic effect of a leaf extract from Gymnema sylvestre in non-insulin-dependent diabetes mellitus patients. Journal of Ethnopharmacology. https://pubmed.ncbi.nlm.nih.gov/2259217/
5. Shanmugasundaram ER, Rajeswari G, Baskaran K, et al. (1990). Use of Gymnema sylvestre leaf extract in the control of blood glucose in insulin-dependent diabetes mellitus. Journal of Ethnopharmacology. https://pubmed.ncbi.nlm.nih.gov/2259216/
6. Devangan S, Varghese B, Johny E, et al. (2021). The effect of Gymnema sylvestre supplementation on glycemic control in type 2 diabetes patients: a systematic review and meta-analysis. Phytotherapy Research. https://pubmed.ncbi.nlm.nih.gov/34467577/
7. Zamani M, Ashtary-Larky D, Nosratabadi S, et al. (2023). The effects of Gymnema sylvestre supplementation on lipid profile, glycemic control, blood pressure, and anthropometric indices in adults: a systematic review and meta-analysis. Phytotherapy Research. https://pubmed.ncbi.nlm.nih.gov/36580574/
8. Gaytán Martínez LA, Sánchez-Ruiz LA, Zuñiga LY, et al. (2021). Effect of Gymnema sylvestre administration on glycemic control, insulin secretion, and insulin sensitivity in patients with impaired glucose tolerance. Journal of Medicinal Food. https://pubmed.ncbi.nlm.nih.gov/32460589/
9. Shimizu K, Iino A, Nakajima J, et al. (1997). Suppression of glucose absorption by some fractions extracted from Gymnema sylvestre leaves. Journal of Veterinary Medical Science. https://pubmed.ncbi.nlm.nih.gov/9152931/
10. Wang LF, Luo H, Miyoshi M, et al. (1998). Inhibitory effect of gymnemic acid on intestinal absorption of oleic acid in rats. Canadian Journal of Physiology and Pharmacology. https://pubmed.ncbi.nlm.nih.gov/10100884/
11. Shimizu K, Ozeki M, Iino A, et al. (2001). Structure-activity relationships of triterpenoid derivatives extracted from Gymnema inodorum leaves on glucose absorption. Japanese Journal of Pharmacology. https://pubmed.ncbi.nlm.nih.gov/11459125/
12. Yoshikawa M, Murakami T, Kadoya M, et al. (1997). Medicinal foodstuffs. IX. The inhibitors of glucose absorption from the leaves of Gymnema sylvestre R. Br. (Asclepiadaceae): structures of gymnemosides a and b. Chemical & Pharmaceutical Bulletin. https://pubmed.ncbi.nlm.nih.gov/9353896/
13. Kang MH, Lee MS, Choi MK, et al. (2012). Hypoglycemic activity of Gymnema sylvestre extracts on oxidative stress and antioxidant status in diabetic rats. Journal of Agricultural and Food Chemistry. https://pubmed.ncbi.nlm.nih.gov/22360666/
14. Stice E, Yokum S, Gau JM (2017). Gymnemic acids lozenge reduces short-term consumption of high-sugar food: a placebo controlled experiment. Journal of Psychopharmacology. https://pubmed.ncbi.nlm.nih.gov/28944714/
15. Turner S, Diako C, Kruger R, et al. (2020). Consuming Gymnema sylvestre reduces the desire for high-sugar sweet foods. Nutrients. https://pubmed.ncbi.nlm.nih.gov/32290122/
16. Pickrahn S, Dawid C, Hofmann T (2021). Sensory-guided multidimensional exploration of antisweet principles from Gymnema sylvestre (Retz) Schult. Journal of Agricultural and Food Chemistry. https://pubmed.ncbi.nlm.nih.gov/33970622/
17. Al-Khayri JM, Sudheer WN, Banadka A, et al. (2023). Biotechnological approaches for the production of gymnemic acid from Gymnema sylvestre R. Br. Applied Microbiology and Biotechnology. https://pubmed.ncbi.nlm.nih.gov/37266583/
18. Preuss HG, Bagchi D, Bagchi M, et al. (2004). Effects of a natural extract of (-)-hydroxycitric acid (HCA-SX) and a combination of HCA-SX plus niacin-bound chromium and Gymnema sylvestre extract on weight loss. Diabetes, Obesity and Metabolism. https://pubmed.ncbi.nlm.nih.gov/15056124/
19. Sigoillot M, Brockhoff A, Neiers F, et al. (2018). The crystal structure of gurmarin, a sweet taste-suppressing protein: identification of the amino acid residues essential for inhibition. Chemical Senses. https://pubmed.ncbi.nlm.nih.gov/30137256/

View all 19 references▾